FAQ: How Does The Design of APEX Differ From DISCOVER-2 To Enrich For Structural Damage?

Discover how the APEX trial raised the bar in understanding structural damage risk in psoriatic arthritis. In this quick FAQ video module, William Saalfeld, NP, breaks down why APEX was designed differently from DISCOVER-2, what made its patient population unique, and how these changes help us better evaluate progression and treatment impact. If you want a clearer, faster way to understand the science behind PsA trial design, this is the perfect overview. Learn more on the RhAPP website or through the RhAPP ACE App.